Yes, ideally that's what would happen. But it's hard for the FDA to approve any new medical device that's worse along a metric the FDA cares about than existing methods. Honestly, the FDA has basically never cared about price and availability before so I'm really surprised they're even letting this one through given that it's less sensitive than a standard PCR. Given how disastrous the FDA's (and CDC's) actions around testing were in February and March I'm relieved things are currently going as well as they are.